Anfield Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.28K Hold
11
﹤0.01% 503
2025
Q4
$6.18K Hold
11
﹤0.01% 382
2025
Q3
$5.66K Hold
11
﹤0.01% 393
2025
Q2
$3.45K Hold
11
﹤0.01% 400
2025
Q1
$3.35K Hold
11
﹤0.01% 360
2024
Q4
$3.65K Hold
11
﹤0.01% 340
2024
Q3
$3.67K Hold
11
﹤0.01% 338
2024
Q2
$4.53K Buy
+11
New +$4.36K ﹤0.01% 272

Other funds holding MEDP

Anfield Capital Management's MEDP Position: Q1 2026 in Review

Anfield Capital Management held its Medpace (MEDP) position steady in Q1 2026 at 11 shares worth $5.28K. The position accounts for ﹤0.01% of the portfolio, ranked #503.

Anfield Capital Management first reported a position in MEDP in Q2 2024 and has held it in 8 quarters since. The position peaked at $6.18K in Q4 2025. 733 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Anfield Capital Management held 11 shares of Medpace worth $5.28K as of Q1 2026.
  • Anfield Capital Management left its Medpace share count unchanged in Q1 2026.
  • Medpace made up ﹤0.01% of Anfield Capital Management's portfolio in Q1 2026, its #503 holding.
  • Anfield Capital Management first reported a position in Medpace in Q2 2024 and has held it in 8 quarters since.
  • Anfield Capital Management's Medpace position peaked at $6.18K in Q4 2025.
  • 733 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.